Location History:
- Yonkers, NY (US) (1998)
- Washington, DC (US) (2001 - 2005)
Company Filing History:
3 out of 1,345 
1 out of 3 Years Active: 1998-2005
Title: The Innovations of David C Bowen
Introduction
David C Bowen is a notable inventor based in Washington, DC. He has made significant contributions to the field of biotechnology, particularly in the area of tyrosine kinase receptors and ligands. With a total of four patents to his name, Bowen's work has implications for both diagnostic and therapeutic methods.
Latest Patents
Bowen's latest patents focus on a gene designated as musk, which encodes a novel tyrosine kinase receptor expressed in high levels in denervated muscle. The invention provides an isolated polypeptide that activates the MuSK receptor. Additionally, it includes a polypeptide that is functionally equivalent to the MuSK activating polypeptide. The patents also describe assay systems that can detect and measure ligands that bind to the musk gene product. Furthermore, the invention outlines diagnostic and therapeutic methods based on molecules that activate MuSK.
Career Highlights
Throughout his career, David C Bowen has worked with prominent companies in the biotechnology sector, including Regeneron Pharmaceuticals, Inc. and Neuralstem Biopharmaceuticals Ltd. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.
Collaborations
Bowen has collaborated with several professionals, including David M Valenzuela and David J Glass. These partnerships have likely enhanced his research and development efforts.
Conclusion
David C Bowen's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and therapies.